Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

Eri Ito, Yoshinao Muro, Akitaka Shibata, Kazumitsu Sugiura, Masashi Akiyama

研究成果: Article査読

1 被引用数 (Scopus)

抄録

Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

本文言語English
ジャーナルDermatology Online Journal
20
8
出版ステータスPublished - 2014
外部発表はい

All Science Journal Classification (ASJC) codes

  • 皮膚病学

フィンガープリント

「Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル